Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

Exclusion Criteria

• •Pregnant (including ectopic pregnancy) or breastfeeding patient.
• •Patients with a documented diagnosis of cancer.
• •Patients with a lymphatic, hematologic or coagulation disorder.
• •Patients with a known or suspected hypersensitivity to blood, blood products or any constituent of Adhexil™.
• •Patients who are immunocompromised, possess autoimmune disorders, or who are routinely taking anticoagulants.
• •Patients who have participated in another clinical study within 30 days of enrolment.
• •Investigator's opinion that the patient is medically unfit or would be at major risk if enrolled into the study.